BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31436532)

  • 1. Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B.
    Vögtle T; Sharma S; Mori J; Nagy Z; Semeniak D; Scandola C; Geer MJ; Smith CW; Lane J; Pollack S; Lassila R; Jouppila A; Barr AJ; Ogg DJ; Howard TD; McMiken HJ; Warwicker J; Geh C; Rowlinson R; Abbott WM; Eckly A; Schulze H; Wright GJ; Mazharian A; Fütterer K; Rajesh S; Douglas MR; Senis YA
    Elife; 2019 Aug; 8():. PubMed ID: 31436532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling ITIM receptor G6b-B from tyrosine phosphatases Shp1 and Shp2 disrupts murine platelet homeostasis.
    Geer MJ; van Geffen JP; Gopalasingam P; Vögtle T; Smith CW; Heising S; Kuijpers MJE; Tullemans BME; Jarvis GE; Eble JA; Jeeves M; Overduin M; Heemskerk JWM; Mazharian A; Senis YA
    Blood; 2018 Sep; 132(13):1413-1425. PubMed ID: 29891536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice lacking the ITIM-containing receptor G6b-B exhibit macrothrombocytopenia and aberrant platelet function.
    Mazharian A; Wang YJ; Mori J; Bem D; Finney B; Heising S; Gissen P; White JG; Berndt MC; Gardiner EE; Nieswandt B; Douglas MR; Campbell RD; Watson SP; Senis YA
    Sci Signal; 2012 Oct; 5(248):ra78. PubMed ID: 23112346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function.
    Mazharian A; Mori J; Wang YJ; Heising S; Neel BG; Watson SP; Senis YA
    Blood; 2013 May; 121(20):4205-20. PubMed ID: 23509158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital macrothrombocytopenia with focal myelofibrosis due to mutations in human G6b-B is rescued in humanized mice.
    Hofmann I; Geer MJ; Vögtle T; Crispin A; Campagna DR; Barr A; Calicchio ML; Heising S; van Geffen JP; Kuijpers MJE; Heemskerk JWM; Eble JA; Schmitz-Abe K; Obeng EA; Douglas M; Freson K; Pondarré C; Favier R; Jarvis GE; Markianos K; Turro E; Ouwehand WH; Mazharian A; Fleming MD; Senis YA
    Blood; 2018 Sep; 132(13):1399-1412. PubMed ID: 29898956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif protein.
    Senis YA; Tomlinson MG; García A; Dumon S; Heath VL; Herbert J; Cobbold SP; Spalton JC; Ayman S; Antrobus R; Zitzmann N; Bicknell R; Frampton J; Authi KS; Martin A; Wakelam MJ; Watson SP
    Mol Cell Proteomics; 2007 Mar; 6(3):548-64. PubMed ID: 17186946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of hierachical protein recruitment to the inhibitory platelet receptor, G6B-b.
    Coxon CH; Sadler AJ; Huo J; Campbell RD
    PLoS One; 2012; 7(11):e49543. PubMed ID: 23185356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2.
    Mori J; Pearce AC; Spalton JC; Grygielska B; Eble JA; Tomlinson MG; Senis YA; Watson SP
    J Biol Chem; 2008 Dec; 283(51):35419-27. PubMed ID: 18955485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G6b-B regulates an essential step in megakaryocyte maturation.
    Becker IC; Nagy Z; Manukjan G; Haffner-Luntzer M; Englert M; Heib T; Vögtle T; Gross C; Bharti R; Dietrich S; Mott K; Heck J; Stegmaier S; Baranowsky A; Schinke T; Schlegel N; Heckel T; Stegner D; Pleines I; Ignatius A; Schulze H; Nieswandt B
    Blood Adv; 2022 May; 6(10):3155-3161. PubMed ID: 35134123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of congenital thrombocytopenia and decreased collagen reactivity in G6b-B-deficient mice.
    Mazharian A; Maître B; Bornert A; Hennequin D; Lourenco-Rodrigues M; Geer MJ; Smith CW; Heising S; Walter M; Montel F; Walker LSK; de la Salle H; Watson SP; Gachet C; Senis YA
    Blood Adv; 2023 Jan; 7(1):46-59. PubMed ID: 36269841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of murine platelet homeostasis by the kinase Csk and phosphatase CD148.
    Mori J; Nagy Z; Di Nunzio G; Smith CW; Geer MJ; Al Ghaithi R; van Geffen JP; Heising S; Boothman L; Tullemans BME; Correia JN; Tee L; Kuijpers MJE; Harrison P; Heemskerk JWM; Jarvis GE; Tarakhovsky A; Weiss A; Mazharian A; Senis YA
    Blood; 2018 Mar; 131(10):1122-1144. PubMed ID: 29301754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice Lacking the Inhibitory Collagen Receptor LAIR-1 Exhibit a Mild Thrombocytosis and Hyperactive Platelets.
    Smith CW; Thomas SG; Raslan Z; Patel P; Byrne M; Lordkipanidzé M; Bem D; Meyaard L; Senis YA; Watson SP; Mazharian A
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):823-835. PubMed ID: 28336561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ITIM receptors: more than just inhibitors of platelet activation.
    Coxon CH; Geer MJ; Senis YA
    Blood; 2017 Jun; 129(26):3407-3418. PubMed ID: 28465343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting platelet inhibition receptors for novel therapies: PECAM-1 and G6b-B.
    Soriano Jerez EM; Gibbins JM; Hughes CE
    Platelets; 2021 Aug; 32(6):761-769. PubMed ID: 33646086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors.
    Xu X; Masubuchi T; Cai Q; Zhao Y; Hui E
    Elife; 2021 Nov; 10():. PubMed ID: 34734802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G6b-B antibody-based cis-acting platelet receptor inhibitors (CAPRIs) as a new family of anti-thrombotic therapeutics.
    Mazharian A; Bertin O; Sarkar A; Augros J; Bornert A; Loubière C; Jönsson F; Warwicker J; Abbott WM; Dushek O; Vayne C; Rauova L; Fütterer K; Rollin J; Poncz M; Senis YA
    bioRxiv; 2024 May; ():. PubMed ID: 38798354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A; Guimond S; Rapraeger AC
    Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel inhibitory receptor G6B is expressed on the surface of platelets and attenuates platelet function in vitro.
    Newland SA; Macaulay IC; Floto AR; de Vet EC; Ouwehand WH; Watkins NA; Lyons PA; Campbell DR
    Blood; 2007 Jun; 109(11):4806-9. PubMed ID: 17311996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G6b-B cell surface inhibitory receptor expression is highly restricted to CD4+ T-cells and induced by interleukin-4-activated STAT6 pathway.
    Li J; Cadeiras M; Prinz von Bayern M; Zhang L; Colovai AI; Dedrick R; Jaffe EA; Suciu-Foca N; Deng MC
    Hum Immunol; 2007 Aug; 68(8):708-14. PubMed ID: 17678728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G6b, a novel immunoglobulin superfamily member encoded in the human major histocompatibility complex, interacts with SHP-1 and SHP-2.
    de Vet EC; Aguado B; Campbell RD
    J Biol Chem; 2001 Nov; 276(45):42070-6. PubMed ID: 11544253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.